Clinical trials in Piotrkow Trybunalski – page 4

44 clinical trials in Piotrkow Trybunalski, Poland. Every trial is listed in the EU Clinical Trials Register and updated daily.

Our site in PolandBadaniaKliniczne.pl

Piotrkow Trybunalski at a glance

clinical trials

Paediatric trials0
Research sites0

Quick filters

44 trials in Piotrkow Trybunalski

Open in trial search

Bladder transitional cell carcinoma

Not recruiting

Study on TAR-200 and Cetrelimab for Patients with High-Risk Non-Muscle Invasive Bladder Cancer Who Have Not Received BCG Treatment

Registered drugNo placebo

Study on TAR-200 and Cetrelimab for Patients with High-Risk Non-Muscle Invasive Bladder Cancer Who Have Not Received BCG Treatment

Registered drugNo placebo

Poland

Participants:18–64 years · 65+ years
Substances:Cetrelimab
Sponsor:Janssen Cilag International

Contact Research Centre

Cardiac failure chronic+1

Not recruiting

Study on the Safety of Starting Vericiguat at 5 mg in Patients with Chronic Heart Failure with Reduced Ejection Fraction

InvestigationalNo placebo

Study on the Safety of Starting Vericiguat at 5 mg in Patients with Chronic Heart Failure with Reduced Ejection Fraction

InvestigationalNo placebo

Poland

Participants:18–64 years · 65+ years
Substances:Vericiguat
Sponsor:Bayer AG

Contact Research Centre

Colitis ulcerative

Not recruiting

Long-Term Safety Study of Obefazimod for Patients with Moderate to Severe Ulcerative Colitis

InvestigationalNo placebo

Long-Term Safety Study of Obefazimod for Patients with Moderate to Severe Ulcerative Colitis

InvestigationalNo placebo

Poland

Participants:18–64 years · 65+ years
Substances:Obefazimod
Sponsor:Abivax

Contact Research Centre

Relapsing multiple sclerosis

Not recruiting

Study on the Effectiveness and Safety of Remibrutinib Compared to Teriflunomide for Patients with Relapsing Multiple Sclerosis

Registered drug

Study on the Effectiveness and Safety of Remibrutinib Compared to Teriflunomide for Patients with Relapsing Multiple Sclerosis

Registered drug

Poland

Participants:18–64 years
Substances:Charcoal, Activated
Sponsor:Novartis Pharma AG

Contact Research Centre

Study on the Effectiveness and Safety of Secukinumab for Adults with Moderate to Severe Rotator Cuff Tendinopathy

Not recruiting

Registered drug

Study on the Effectiveness and Safety of Secukinumab for Adults with Moderate to Severe Rotator Cuff Tendinopathy

Registered drug

Poland

Participants:18–64 years
Substances:Secukinumab
Sponsor:Novartis Pharma AG

Contact Research Centre

Atrial fibrillation+2

Not recruiting

Study on Asundexian and Apixaban for Preventing Stroke in Adults with Atrial Fibrillation at Risk for Stroke

Registered drug

Study on Asundexian and Apixaban for Preventing Stroke in Adults with Atrial Fibrillation at Risk for Stroke

Registered drug

Poland

Participants:18–64 years · 65+ years
Substances:Apixaban
Sponsor:Bayer AG

Contact Research Centre

Asthma

Not recruiting

Study on RPT193 for Adults with Moderate-to-Severe Asthma Partially Controlled by Inhaled Corticosteroids and Long-Acting Beta 2 Agonists

Registered drug

Study on RPT193 for Adults with Moderate-to-Severe Asthma Partially Controlled by Inhaled Corticosteroids and Long-Acting Beta 2 Agonists

Registered drug

Poland

Participants:18–64 years · 65+ years
Substances:Salbutamol Sulfate
Sponsor:Rapt Therapeutics Inc.

Contact Research Centre

Colitis ulcerative

Not recruiting

Study of RO7790121 Treatment for Adults with Moderate to Severe Ulcerative Colitis: Testing Effectiveness and Safety in Initial and Long-term Therapy

Investigational

Study of RO7790121 Treatment for Adults with Moderate to Severe Ulcerative Colitis: Testing Effectiveness and Safety in Initial and Long-term Therapy

Investigational

Poland

Participants:18–64 years · 65+ years
Sponsor:F. Hoffmann-La Roche AG

Contact Research Centre

Other cities in Poland

The busiest research cities in the country

All 239 cities in Poland

Clinical research in Piotrkow Trybunalski

What the registry says about research in the country

01 Oncology Research

Studies focusing on innovative treatments for bladder cancer, including combinations with immunotherapy agents and novel therapeutic approaches for head and neck cancer. Multiple trials are evaluating new combination therapies for prostate cancer.

Non-muscle invasive bladder cancer treatments
Head and neck squamous cell carcinoma therapies
Metastatic prostate cancer interventions

Research emphasizes improving survival rates and treatment outcomes through targeted therapies.

02 Cardiovascular Studies

Comprehensive research into heart failure treatments, particularly focusing on reduced ejection fraction conditions. Studies evaluate new medications for stroke prevention in patients with atrial fibrillation.

Heart failure management strategies
Stroke prevention therapies
Cardiovascular disease prevention

Trials aim to improve patient outcomes and develop more effective treatment options.

03 Autoimmune Conditions

Innovative research targeting multiple sclerosis, rheumatoid arthritis, and Sjögren's syndrome. Studies evaluate novel therapeutic approaches and biosimilar medications.

Multiple sclerosis treatments
Rheumatoid arthritis therapies
Inflammatory bowel disease interventions

Focus on developing targeted treatments to improve disease management and patient quality of life.

Back to Poland All countries